Patent · US Active

Adeno-associated virus purification methods

US11000561B2 · kind B2 · utility

0Cited by

5References

47Claims

0Family size

Assignee

Takeda Pharmaceutical Company Limited · JP

Inventors

Christian Fiedler · Wien, AT
Leopold Grillberger · Wien, AT
Meinhard Hasslacher · Wien, AT
Barbara Kraus · Obersdorf, AT
Dominik Mittergradnegger · Wien, AT
Stefan Reuberger · Wien, AT
Horst Schafhauser · Wien, AT
Marian Bendik · Bratislava, SK

Key dates

Filing date	Nov 3, 2017
Grant date	May 11, 2021
Priority date	—
Expiry date	Nov 3, 2037

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC12N2750/14151
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

Provided herein are methods of producing an adeno-associated virus (AAV) product, methods of purifying adeno-associated virus, and methods of purifying full AAV capsids from a concentrated AAV fraction comprising empty AAV capsids and full AAV capsids.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.